Salud Pública de México (Nov 2021)

Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020

  • Ana Cristina Basto-Abreu,
  • Nancy López-Olmedo,
  • Rosalba Rojas-Martínez,
  • Carlos A. Aguilar-Salinas,
  • Vanessa Vianey De la Cruz-Góngora,
  • Juan Rivera-Dommarco,
  • Teresa Shamah-Levy,
  • Martín Romero-Martínez,
  • Simón Barquera,
  • Salvador Villalpando,
  • Tonatiuh Barrientos-Gutiérrez

DOI
https://doi.org/10.21149/12842
Journal volume & issue
Vol. 63, no. 6, Nov-Dic
pp. 725 – 733

Abstract

Read online

Objective. To estimate the prevalence of diabetes (diagnosed and undiagnosed), glycemic control in Mexico, and its associated factors. Materials and methods. We used data from Ensanut 2018 (n=12 648) and 2020 (n=2 309). We defined diabetes as fasting glucose ≥126 mg/dl or HbA1c≥6.5% or previously diagnosed; glycemic control was defined as HbA1c<7%. We fitted Poisson regression models to assess the association between diabetes, glycemic control, and potential associated factors. Results. The total prevalence of diabetes was 16.8% in 2018 and 15.7% in 2020. In 2018, 38% of adults with diabetes were unaware of their disease, while in 2020 this figure was 29%. Glycemic control was observed in 42% of participants in 2018 and 39% in 2020. Longer disease duration was associated with lower glycemic control, while older age, having a diet, and being affiliated to IMSS, Pemex, Sedena, or private healthcare were associated with better control. Conclusion. Mexico is among the countries with the highest diabetes prevalence. A high proportion of adults with diabetes did not have a previous diagnosis, and the proportion with glycemic control is low. Strengthening screening to achieve a timely diagnosis, and improving glycemic control, should be key actions in the management of diabetes.

Keywords